Showing results (171-180 of 273) with videos related to

Sort By:
Pageof 28
Transfusion|July 13, 2016
Low incidence of D alloimmunization among patients with a serologic weak D phenotype after D+ transfusionMark H Yazer, Patricia A Brunker, Suzanne Bakdash, et al.
Transfusion|February 7, 2013
Addition of ascorbic acid solution to stored murine red blood cells increases posttransfusion recovery and decreases microparticles and alloimmunizationSean R Stowell, Nicole H Smith, James C Zimring, et al.
Hematology (Amsterdam, Netherlands)|January 6, 2023
Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in traumaMark H Yazer, Gleb Panko, John B Holcomb, et al.
Transfusion|July 16, 2021
Survey to inform trial of low-titer group O whole-blood compared to conventional blood components for children with severe traumatic bleedingJulia H Kolodziej, Julie C Leonard, Cassandra D Josephson, et al.
Transfusion Medicine (Oxford, England)|September 5, 2023
Low-titer group O whole blood in military ground ambulances: Lessons from the Israel Defense Forces initial experienceTomer Talmy, Michael Malkin, Akiva Esterson, et al.
The Journal of Bone and Joint Surgery. American Volume|November 22, 2016
Coagulation Profile of Patients with Adolescent Idiopathic Scoliosis Undergoing Posterior Spinal FusionPatrick Bosch, Tanya S Kenkre, Joanne A Londino, et al.
General Thoracic and Cardiovascular Surgery|May 1, 2020
Coagulation ability when separating from cardiopulmonary bypass with and without fresh frozen plasma: a pilot studyTakahiro Tamura, Shuichi Yokota, Toshiaki Ito, et al.
Anesthesia and Analgesia|January 27, 2004
Preoperative autologous donation versus cell salvage in the avoidance of allogeneic transfusion in patients undergoing radical retropubic prostatectomyJonathan H Waters, Julia ShinJung Lee, Eric Klein, et al.
Transfusion|April 3, 2021
Injured recipients of low-titer group O whole blood have similar clinical outcomes compared to recipients of conventional component therapy: A single-center, retrospective studyMark H Yazer, Andrew Freeman, Ian M Harrold, et al.
Transfusion|February 7, 2020
How do you… decide which platelet bacterial risk mitigation strategy to select for your hospital-based transfusion service?Wen Lu, Meghan Delaney, Willy A Flegel, et al.
Pageof 28